Lung Cancer 2021, Part I
نویسندگان
چکیده
THORACIC SURGERY CLINICS www.thoracic.theclinics.com Consulting Editor VIRGINIA R. LITLE August 2021 • Volume 31 Number 3
منابع مشابه
Chemotherapy for Non–Small-Cell Lung Cancer, Part I
Non-small-cell lung cancer (NSCLC) accounts for approximately 80% of all lung tumors. Patients diagnosed with early-stage disease generally undergo surgery, but up to 50% develop local or distant recurrences. The benefit of chemotherapy in this disease is modest, but new drugs and combined strategies offer hope of improved survival rates. Because the disease recurs outside the chest in 70% of c...
متن کاملThe Serological Diagnosis of Cancer. Part I
A search of the literature dealing with the serological diagnosis of malignant conditions reveals that a t least two score of methods have been proposed which attempt to utilise for diagnosis special characteristics of the serum from patients suffering from cancer. Some of these, notably the Meiostagmin reaction of AscoIi and Izar, the Shaw-Mackenzie reaction, and the elaboration of the latter ...
متن کاملPulmonary Actinomycosis Mimicking Lung Cancer
Herein, we reported on a case of solid type of pulmonary actinomycosis in a 10-year-old boy. He had productive cough for 40 days. Bronchoscopy was normal. Cmputed tomography revealed a solid large mass in the upper lobe of his left lung with mimicking malignant leisions. He was referred for surgery and underwent left upper lobectomy. Macroscopically, the specimen measured 13×9×5 cm and was crea...
متن کاملPrognostic Factors in Stage I Lung Cancer.
Lung cancer (LC) still has a very poor prognosis, with overall 5-year survival rates of 10%–20% in most countries.1 Nevertheless, the life expectancy of individual patients ranges widely, depending on specific circumstances: in non-small cell lung cancer (NSCLC), 5-year survival in stage IV disease is 2%–3%, but can be as high as 70% in stage I patients with fully resected disease.2 With regard...
متن کاملLung Cancer Associated with Neurofibromatosis Type I
Lung cancer associated with neurofibromatosis type I is considered very rare, and only a few case reports have been described in the literature. There is some evidence that a genetic linkage between neurofibromatosis and carcinogenesis in the lung may exist. We present a 42-year-old female, lifetime nonsmoker with a known history of neurofibromatosis type I, free of respiratory symptoms, who un...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Thoracic Surgery Clinics
سال: 2021
ISSN: ['1547-4127']
DOI: https://doi.org/10.1016/s1547-4127(21)00049-9